Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosemary Lawrence-Henderson

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Bioanalysis|November 8, 2021
A competitive ligand-binding assay to detect neutralizing antibodies to a bispecific drug using a multiplex Meso Scale Discovery platformVitaly Ablamunits, Soma Basak, Rosemary Lawrence-Henderson, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 2, 2025
A Competitive Ligand-Binding Assay for Simultaneous Detection of Neutralizing Antibodies to Both Arms of a Bispecific DrugVitaly Ablamunits, Soma Basak, Rosemary Lawrence-Henderson, et al.
Pharmaceutical Research|January 28, 2014
One mouse, one pharmacokinetic profile: quantitative whole blood serial sampling for biotherapeuticsAlison P Joyce, Mengmeng Wang, Rosemary Lawrence-Henderson, et al.
The AAPS Journal|December 3, 2017
A Multi-site In-depth Evaluation of the Quanterix Simoa from a User's PerspectiveAllison Given Chunyk, Alison Joyce, Saloumeh K Fischer, et al.
Journal of Immunological Methods|September 3, 2013
Bioanalytical platform comparison using a generic human IgG PK assay formatBeth A Leary, Rosemary Lawrence-Henderson, Carolyn Mallozzi, et al.
Pharmaceutical Research|November 6, 2013
Quantitative analysis of target coverage and germinal center response by a CXCL13 neutralizing antibody in a T-dependent mouse immunization modelJoanne Brodfuehrer, Andrew Rankin, Jason Edmonds, et al.
Journal of Parkinson'S Disease|February 3, 2020
An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson's Disease and G2019S LRRK2 CohortsShalini Padmanabhan, Thomas A Lanz, Donal Gorman, et al.
Mabs|January 18, 2021
Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumorsAdam R Root, Gurkan Guntas, Madan Katragadda, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Bioanalysis|November 8, 2021
A competitive ligand-binding assay to detect neutralizing antibodies to a bispecific drug using a multiplex Meso Scale Discovery platformVitaly Ablamunits, Soma Basak, Rosemary Lawrence-Henderson, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 2, 2025
A Competitive Ligand-Binding Assay for Simultaneous Detection of Neutralizing Antibodies to Both Arms of a Bispecific DrugVitaly Ablamunits, Soma Basak, Rosemary Lawrence-Henderson, et al.
Pharmaceutical Research|January 28, 2014
One mouse, one pharmacokinetic profile: quantitative whole blood serial sampling for biotherapeuticsAlison P Joyce, Mengmeng Wang, Rosemary Lawrence-Henderson, et al.
The AAPS Journal|December 3, 2017
A Multi-site In-depth Evaluation of the Quanterix Simoa from a User's PerspectiveAllison Given Chunyk, Alison Joyce, Saloumeh K Fischer, et al.
Journal of Immunological Methods|September 3, 2013
Bioanalytical platform comparison using a generic human IgG PK assay formatBeth A Leary, Rosemary Lawrence-Henderson, Carolyn Mallozzi, et al.
Pharmaceutical Research|November 6, 2013
Quantitative analysis of target coverage and germinal center response by a CXCL13 neutralizing antibody in a T-dependent mouse immunization modelJoanne Brodfuehrer, Andrew Rankin, Jason Edmonds, et al.
Journal of Parkinson'S Disease|February 3, 2020
An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson's Disease and G2019S LRRK2 CohortsShalini Padmanabhan, Thomas A Lanz, Donal Gorman, et al.
Mabs|January 18, 2021
Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumorsAdam R Root, Gurkan Guntas, Madan Katragadda, et al.
Pageof 1